Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Exp Mol Pathol ; 105(3): 243-251, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30189187

RESUMEN

OBJECTIVE: We have previously reported the aberrant expression of vimentin in human oral premalignant lesions and a 4-Nitroquinoline 1-oxide (4NQO) model of rat lingual carcinogenesis. Hence, we wanted to understand whether the expression of vimentin in early stage contributes to the process of transformation. STUDY DESIGN: Vimentin was stably expressed in oral premalignant lesion derived cells (vimentin negative) and various transformation related phenotypic assays were performed. Since vimentin alone failed to transform the cells, an additional carcinogenic stimulus benzo[a]pyrene (BP) was used. Concomitantly, immunohistochemistry (IHC) was performed on oral leukoplakia and tumor tissues for studying the expression of vimentin and E-cadherin. RESULTS: Exogenous expression of vimentin led to the appearance of EMT and stemness-related signatures. Further, upon BP treatment, vimentin expressing clones showed an increase in vitro and in vivo transformation efficiency. Importantly, high vimentin-low E-cadherin expression significantly correlated with the grade of dysplasia, as also with the lymph node metastasis in oral tumors. CONCLUSION: Our study suggests that the expression of vimentin in early stages may be beneficial, although not sufficient to achieve transformation. Further, high vimentin-low E-cadherin expression, if validated in more number of early oral lesions, may prove useful in the identification of high risk human premalignant lesions.


Asunto(s)
Transformación Celular Neoplásica/metabolismo , Transición Epitelial-Mesenquimal/fisiología , Neoplasias de la Boca/patología , Lesiones Precancerosas/patología , Vimentina/metabolismo , Animales , Transformación Celular Neoplásica/patología , Xenoinjertos , Humanos , Ratones , Ratones Desnudos , Neoplasias de la Boca/metabolismo , Lesiones Precancerosas/metabolismo
2.
Exp Cell Res ; 360(2): 125-137, 2017 11 15.
Artículo en Inglés | MEDLINE | ID: mdl-28867478

RESUMEN

BPAG1e and Plectin are hemidesmosomal linker proteins which anchor intermediate filament proteins to the cell surface through ß4 integrin. Recent reports indicate that these proteins play a role in various cellular processes apart from their known anchoring function. However, the available literature is inconsistent. Further, the previous study from our laboratory suggested that Keratin8/18 pair promotes cell motility and tumor progression by deregulating ß4 integrin signaling in oral squamous cell carcinoma (OSCC) derived cells. Based on these findings, we hypothesized that linker proteins may have a role in neoplastic progression of OSCC. Downregulation of hemidesmosomal linker proteins in OSCC derived cells resulted in reduced cell migration accompanied by alterations in actin organization. Further, decreased MMP9 activity led to reduced cell invasion in linker proteins knockdown cells. Moreover, loss of these proteins resulted in reduced tumorigenic potential. SWATH analysis demonstrated upregulation of N-Myc downstream regulated gene 1 (NDRG1) in linker proteins downregulated cells as compared to vector control cells. Further, the defects in phenotype upon linker proteins ablation were rescued upon loss of NDRG1 in linker proteins knockdown background. These data together indicate that hemidesmosomal linker proteins regulate cell motility, invasion and tumorigenicity possibly through NDRG1 in OSCC derived cells.


Asunto(s)
Carcinogénesis/genética , Carcinoma de Células Escamosas/patología , Movimiento Celular/genética , Proteínas del Citoesqueleto/fisiología , Hemidesmosomas/fisiología , Neoplasias de la Boca/patología , Animales , Carcinogénesis/patología , Carcinoma de Células Escamosas/genética , Línea Celular Tumoral , Proteínas del Citoesqueleto/genética , Distonina/fisiología , Células HEK293 , Hemidesmosomas/genética , Hemidesmosomas/metabolismo , Humanos , Ratones , Ratones Endogámicos NOD , Ratones SCID , Neoplasias de la Boca/genética , Invasividad Neoplásica , Plectina/genética , Plectina/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA